EMEA-001075-PIP04-15-M04
Key facts
Invented name |
Evenity
|
Active substance |
Romosozumab
|
Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
Decision number |
P/0551/2021
|
PIP number |
EMEA-001075-PIP04-15-M04
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Treatment of osteoporosis
|
Route(s) of administration |
Subcutaneous use
|
Contact for public enquiries |
UCB Pharma S.A.
E-mail: UCBCares.UK@ucb.com |
Decision type |
PM: decision on the application for modification of an agreed PIP
|